“I want to focus on three aspects
Pre print servers”
“In my last post on the lack of accessibility of Gold Open Access for early career researchers (ECRs), I mentioned that in my opinion Green Open Access was a very imperfect solution – in fact, hardly a solution at all. I expand here on why that is the case, and why a focus on green OA presents new challenges for publication practices which compound the – already many – challenges of moving towards a greater accessibility of research. Not all OA initiatives are equal. Green Open Access, by far the commonest kind, refers to the depositing of a non-final version of the published manuscript into a research repository – generally either an institutional repository (managed by the university with which the researcher is affiliated), a subject-specific repository (such as ArXiv/SocArXiv), an academic networking website such as Academia.edu, ResearchGate, or Mendeley, or a personal website. Various publishers have rules on what version can be posted where and when, with the most common being that accepted manuscripts (after peer-review, but before proofreading and typesetting) can be made public in repositories after an embargo period, while the “version of record” – the published version – may not be shared publicly for free. The published article remains accessible only with paid access (with publishers either explicitly authorizing (SAGE) or tacitly tolerating the private sharing of full articles.”
“Almost 1,500 papers have been uploaded to SocArXiv since its launch last year. Up to now the platform has operated alongside the peer-review journal system rather than seriously disrupting it. Looking ahead to the next stage of its development, Philip Cohen considers how SocArXiv might challenge the peer review system to be more efficient and transparent, firstly by confronting the bias that leads many who benefit from the status quo to characterise mooted alternatives as extreme. The value and implications of openness at the various decision points in the system must be debated, as should potentially more disruptive innovations such as non-exclusive review and publication or crowdsourcing reviews.”
“Open Therapeutics™ facilitates and enables collaboration among life science researchers around the world!
There are highly qualified scientists everywhere. They want to collaborate. However, there is no comprehensive platform for them to do so – until now!
The Open Therapeutics’ Therapoid™ scientific ecosystem enables much more than just collaboration.
As a web platform for scientific collaboration Therapoid includes:
Open biotechnologies for advancing research and gaining publications,
Funding to further develop open biotechnologies,
An asset exchange that hosts freely available equipment and supplies,
A manuscript development process,
A preprint server for hosting manuscripts.
Goals of Open Therapeutics’ include lowering biotechnology and pharmaceutical costs, reducing the risks and time to develop life-saving therapies, and broadening markets for therapeutics, particularly for underserved populations around the world.”
“An Economics section of the scientific repository arXiv is opening this month. arXiv is internationally acknowledged as a pioneering open access preprint repository. It has transformed the scholarly communication infrastructure of multiple fields of physics and plays an increasingly prominent role in mathematics, computer science, quantitative biology, quantitative finance, and statistics. arXiv is an essential component of scientific communication for many researchers worldwide in order to rapidly and widely disseminate their findings, establish priority of their discoveries, and seek feedback to help improve their work. It is hosted by the Cornell University Library with additional funding from 220 members libraries and several scientific foundations including the Simons Foundation.”